Yousra Bseiso, Badriyah S. Alotaibi, Alaa A. A. Aljabali, Omar Gammoh, Muna Oqal, Mohammad E. Rabeh, Ahmad M. Rabi, Esam Qnais, Abdelrahim Alqudah
{"title":"Isorhamnetin Protects Against Organophosphate-Induced Cardiac Damage in Wistar Rats Through Redox Balance and Nrf2/HO-1 Signalling","authors":"Yousra Bseiso, Badriyah S. Alotaibi, Alaa A. A. Aljabali, Omar Gammoh, Muna Oqal, Mohammad E. Rabeh, Ahmad M. Rabi, Esam Qnais, Abdelrahim Alqudah","doi":"10.1111/bcpt.70197","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Chlorpyrifos (CPF) triggers cardiotoxicity associated with oxidative stress, inflammation and apoptosis. This study investigated whether isorhamnetin, a chemically defined flavonol (3′-<i>O</i>-methylquercetin, C<sub>16</sub>H<sub>12</sub>O<sub>7</sub>, purity ≥ 98%), could mitigate CPF-induced myocardial injury.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Male Wistar rats were randomly divided into control, isorhamnetin, CPF and CPF + isorhamnetin groups. Cardiac biomarkers, oxidative/antioxidant status, and inflammatory and apoptotic mediators in conjunction with histopathology and Nrf2/HO-1 signalization were assessed.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>CPF elevated serum cTnI, CK-MB and LDH (<i>p</i> < 0.001), attaining lower levels after isorhamnetin cotreatment (<i>p</i> < 0.001). TBARS and NO were elevated (<i>p</i> < 0.001), whereas GSH, SOD, catalase and GPx decreased (<i>p</i> < 0.001) after CPF exposure; these indices were reverted with isorhamnetin. CPF increased the expression levels of NF-κB p65, TNF-α, IL-6 and IL-1β proteins and decreased that of IL-10 (<i>p</i> < 0.001), whereas isorhamnetin offset these effects (<i>p</i> < 0.001). Apoptosis was apparent with high Bax and caspase-3 and low Bcl-2 (<i>p</i> < 0.001); all were ameliorated by isorhamnetin. Histopathological alterations caused by CPF were ameliorated. CPF downregulated the expression and activity of Nrf2/HO-1 (<i>p</i> < 0.001), but this pathway was significantly induced by isorhamnetin (<i>p</i> < 0.001).</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Isorhamnetin alleviates CPF-induced cardiotoxicity by restoring redox balance and modulating inflammatory and apoptotic pathways through Nrf2/HO-1 signalling.</p>\n </section>\n </div>","PeriodicalId":8733,"journal":{"name":"Basic & Clinical Pharmacology & Toxicology","volume":"138 4","pages":""},"PeriodicalIF":3.6000,"publicationDate":"2026-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Basic & Clinical Pharmacology & Toxicology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/bcpt.70197","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Chlorpyrifos (CPF) triggers cardiotoxicity associated with oxidative stress, inflammation and apoptosis. This study investigated whether isorhamnetin, a chemically defined flavonol (3′-O-methylquercetin, C16H12O7, purity ≥ 98%), could mitigate CPF-induced myocardial injury.
Methods
Male Wistar rats were randomly divided into control, isorhamnetin, CPF and CPF + isorhamnetin groups. Cardiac biomarkers, oxidative/antioxidant status, and inflammatory and apoptotic mediators in conjunction with histopathology and Nrf2/HO-1 signalization were assessed.
Results
CPF elevated serum cTnI, CK-MB and LDH (p < 0.001), attaining lower levels after isorhamnetin cotreatment (p < 0.001). TBARS and NO were elevated (p < 0.001), whereas GSH, SOD, catalase and GPx decreased (p < 0.001) after CPF exposure; these indices were reverted with isorhamnetin. CPF increased the expression levels of NF-κB p65, TNF-α, IL-6 and IL-1β proteins and decreased that of IL-10 (p < 0.001), whereas isorhamnetin offset these effects (p < 0.001). Apoptosis was apparent with high Bax and caspase-3 and low Bcl-2 (p < 0.001); all were ameliorated by isorhamnetin. Histopathological alterations caused by CPF were ameliorated. CPF downregulated the expression and activity of Nrf2/HO-1 (p < 0.001), but this pathway was significantly induced by isorhamnetin (p < 0.001).
Conclusions
Isorhamnetin alleviates CPF-induced cardiotoxicity by restoring redox balance and modulating inflammatory and apoptotic pathways through Nrf2/HO-1 signalling.
背景:毒死蜱(CPF)引发与氧化应激、炎症和细胞凋亡相关的心脏毒性。本研究探讨了异鼠李素,一种化学定义的黄酮醇(3′- o -甲基槲皮素,C16H12O7,纯度≥98%)是否能减轻cpf诱导的心肌损伤。方法:雄性Wistar大鼠随机分为对照组、异鼠李素组、CPF组和CPF +异鼠李素组。评估心脏生物标志物、氧化/抗氧化状态、炎症和凋亡介质与组织病理学和Nrf2/HO-1信号的关系。结果:CPF升高血清cTnI、CK-MB和LDH (p)结论:异鼠李素通过Nrf2/HO-1信号通路,恢复氧化还原平衡,调节炎症和凋亡通路,减轻CPF诱导的心脏毒性。
期刊介绍:
Basic & Clinical Pharmacology and Toxicology is an independent journal, publishing original scientific research in all fields of toxicology, basic and clinical pharmacology. This includes experimental animal pharmacology and toxicology and molecular (-genetic), biochemical and cellular pharmacology and toxicology. It also includes all aspects of clinical pharmacology: pharmacokinetics, pharmacodynamics, therapeutic drug monitoring, drug/drug interactions, pharmacogenetics/-genomics, pharmacoepidemiology, pharmacovigilance, pharmacoeconomics, randomized controlled clinical trials and rational pharmacotherapy. For all compounds used in the studies, the chemical constitution and composition should be known, also for natural compounds.